Home Search
epidyolex - search results
If you're not happy with the results, please do another search
Brexit’s Medical Cannabis Sting For UK Paediatric Patients
The UK’s Brexit transition period ends on 1 January 2021, and with it access to medical cannabis prescriptions filled in the EU.
From January 1,...
Australia’s TGA Approves Cannabidiol (CBD) Medicine
GW Pharmaceuticals announced last week the Australian Therapeutic Goods Administration (TGA) has approved its cannabidiol medicine Epidyolex for the treatment of seizures associated with...
CBD Medicine Approved For TSC Treatment In The USA
GW Pharmaceuticals has achieved one of its goals for this year - seeing Epidiolex approved for the treatment of seizures associated with tuberous sclerosis...
Cannabidiol Medicine Downscheduled In The UK
GW Pharmaceuticals' Epidyolex has been rescheduled in the UK, making life easier for patients, healthcare professionals and pharmacists.
Epidyolex, which is marketed as Epidiolex in...
Cannabidiol-Based Medicine Descheduled In The USA
GW Pharmaceuticals announced yesterday the United States Drug Enforcement Administration (DEA) has determined Epidiolex is no longer subject to the Controlled Substances Act (CSA),...
GW Pharmaceuticals Turning Big Bucks From CBD
GW Pharmaceuticals (Nasdaq:GWPH) has posted better than expected results on the back of its cannabidiol-based medication Epidiolex.
The company expects its total net product sales...
Poll Results: Use Of Street Cannabis Medicinally In The UK
A new poll reveals 2.8% of the British adult population is using "street cannabis" for medicinal purposes - up to 1.4 million people.
A survey...
Advertisement
